Lawrence M Alleva is Director of Mersana Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRSN, which is worth approximately $0. The most recent transaction as insider was on Jan 06, 2026, when has been sold 578 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Lawrence M Alleva Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2026
SELL
Disposition due to a tender of shares in a change of control transaction
-
578 Reduced 100.0%
0 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
14,467 Added 50.0%
14,467 Common Stock

Also insider at

BFAM
BRIGHT HORIZONS FAMILY SOLUTIONS INC. Consumer Cyclical
ADAP
Adaptimmune Therapeutics PLC Healthcare
GRTX
Galera Therapeutics, Inc. Healthcare
LMA

Lawrence M Alleva

Director
Malvern, PA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Track Activities on MRSN